CMAJ • July 3, 2007; 177 (1). doi:10.1503/cmaj.060730.
© 2007 Canadian Medical Association or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Appendices
Right arrow Online Appendix
Right arrow Résumé
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Birnie, D. H.
Right arrow Articles by Tang, A. S.L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Birnie, D. H., MB ChB MD
Right arrow Articles by Tang, A. S.L., MD
Related Collections
Right arrow Heart failure
Right arrow Patient-caregiver communication
Right arrow Français
Right arrowRelated Article

Research

Use of implantable cardioverter defibrillators in Canadian and US survivors of out-of-hospital cardiac arrest

David H. Birnie, MB ChB MD, Christie Sambell, BSc, Helen Johansen, PhD, Kathryn Williams, MS, Robert Lemery, MD, Martin S. Green, MD, Michael H. Gollob, MD, Douglas S. Lee, MD PhD and Anthony S.L. Tang, MD

From the University of Ottawa Heart Institute (Birnie, Williams, Lemery, Green, Gollob, Tang); the Health Statistics Division (Sambell, Johansen), Statistics Canada, Ottawa; and the Institute for Clinical Evaluative Sciences (Lee), Toronto, Ont.

Correspondence to: Dr. David Birnie, Ottawa Heart Institute, 40 Ruskin Rd., Ottawa ON K1Y 4W7; fax 613 761-4407; dbirnie{at}ottawaheart.ca

Background: Cardiac arrest due to ventricular arrhythmia in the absence of a reversible cause or contraindication has been a class I indication for insertion of an implantable cardioverter defibrillator since 1998. We compared and contrasted the use of implantable cardioverter defibrillator therapy in Canada and the United States among adults who survived a cardiac arrest.

Method: Data on hospital separations from April 1, 1994 through March 31, 2003 were obtained from the Health Person-Oriented Information Database maintained by Statistics Canada and from the US National Hospital Discharge Survey on all patients with a primary diagnosis of cardiac arrest, ventricular fibrillation or ventricular flutter for the same 9-year period. We excluded all records of patients with a secondary diagnosis of acute myocardial infarction.

Results: In Canada, 3793 patients survived to discharge after a cardiac arrest; 628 (16.6%) of these were implanted with a cardioverter defibrillator before discharge. The implant rate rose steadily from 5.4% in 1994/95 to 26.7% in 2002/03. In the United States, 23 688 (30.2%) of 78 538 such survivors received an implantable cardioverter defibrillator before discharge. Logistic regression analysis indicated that sex, age, fiscal year, the hospital's teaching status, hospital size and patient history of heart failure were positive predictors of implantable cardioverter defibrillator implantation. Age, renal failure, liver failure and cancer were negative predictors of receiving an implantable cardioverter defibrillator.

Interpretation: The rate of use of implantable cardioverter defibrillator therapy for cardiac arrest survivors in Canada is increasing, but still is lower than the rate in the United States.


Related Article

Implantable cardioverter defibrillators work — so why aren't we using them?
Christopher S. Simpson, MD
Can. Med. Assoc. J. 2007 177: 49-51. [Full Text] [PDF]



This article has been cited by other articles:


Home page
 EuropaceHome page
P. A. Scott, N. G. Turner, A. Chungh, J. M. Morgan, and P. R. Roberts
Varying implantable cardioverter defibrillator referral patterns from implanting and non-implanting hospitals
Europace, August 1, 2009; 11(8): 1048 - 1051.
[Abstract] [Full Text] [PDF]

Home page
 ICVTSHome page
N. Schulz, K. Puschel, and E. E. Turk
Fatal complications of pacemaker and implantable cardioverter-defibrillator implantation: medical malpractice?
Interactive CardioVascular and Thoracic Surgery, April 1, 2009; 8(4): 444 - 448.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
A. S. Bierman MD MS
Sex matters: gender disparities in quality and outcomes of care
Can. Med. Assoc. J., December 4, 2007; 177(12): 1520 - 1521.
[Full Text] [PDF]

Home page
 CMAJHome page
C. S. Simpson MD
Implantable cardioverter defibrillators work so why aren't we using them?
Can. Med. Assoc. J., July 3, 2007; 177(1): 49 - 51.
[Full Text] [PDF]